Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Schot is active.

Publication


Featured researches published by Robert Schot.


Lung Cancer | 2009

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD

Silvano Dragonieri; Jouke T. Annema; Robert Schot; Marc P. van der Schee; Antonio Spanevello; Pierluigi Carratù; Onofrio Resta; Klaus F. Rabe; Peter J. Sterk

BACKGROUND Exhaled breath contains thousands of gaseous volatile organic compounds (VOCs) that may be used as non-invasive markers of lung disease. The electronic nose analyzes VOCs by composite nano-sensor arrays with learning algorithms. It has been shown that an electronic nose can distinguish the VOCs pattern in exhaled breath of lung cancer patients from healthy controls. We hypothesized that an electronic nose can discriminate patients with lung cancer from COPD patients and healthy controls by analyzing the VOC-profile in exhaled breath. METHODS 30 subjects participated in a cross-sectional study: 10 patients with non-small cell lung cancer (NSCLC, [age 66.4+/-9.0, FEV(1) 86.3+/-20.7]), 10 patients with COPD (age 61.4+/-5.5, FEV(1) 70.0+/-14.8) and 10 healthy controls (age 58.3+/-8.1, FEV(1) 108.9+/-14.6). After 5 min tidal breathing through a non-rebreathing valve with inspiratory VOC-filter, subjects performed a single vital capacity maneuver to collect dried exhaled air into a Tedlar bag. The bag was connected to the electronic nose (Cyranose 320) within 10 min, with VOC-filtered room air as baseline. The smellprints were analyzed by onboard statistical software. RESULTS Smellprints from NSCLC patients clustered distinctly from those of COPD subjects (cross validation value [CVV]: 85%; M-distance: 3.73). NSCLC patients could also be discriminated from healthy controls in duplicate measurements (CVV: 90% and 80%, respectively; M-distance: 2.96 and 2.26). CONCLUSION VOC-patterns of exhaled breath discriminates patients with lung cancer from COPD patients as well as healthy controls. The electronic nose may qualify as a non-invasive diagnostic tool for lung cancer in the future.


European Respiratory Journal | 2006

Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma

I.H. van Veen; Peter J. Sterk; Robert Schot; Stefanie A. Gauw; Klaus F. Rabe; E.H. Bel

Alveolar nitric oxide (NO) is a measure of peripheral airway inflammation in asthma, potentially associated with disease severity. The relationship between alveolar NO and physiological tests of peripheral airway (dys)function has not been investigated. The present authors hypothesised that peripheral airway inflammation and dysfunction are inter-related and associated with asthma severity. Alveolar NO was compared between 17 patients with mild-to-moderate asthma and 14 patients with severe asthma and related to total lung capacity (TLC), residual volume (RV)/TLC, thoracic gas volume (FRC), slope of the single breath nitrogen washout curve (dN2), closing capacity (CC)/TLC and fall in forced vital capacity at the provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second. In patients with severe asthma, strong correlations were found between alveolar NO and RV/TLC % pred, FRC % pred, dN2, and CC/TLC. Patients with oral steroid-dependent asthma had higher alveolar NO levels (2.7 ppb) compared with the other patients with severe (0.6 ppb) and mild-to-moderate asthma (0.3 ppb). The present authors conclude that alveolar nitric oxide is closely related to parameters of peripheral airway dysfunction in patients with severe asthma, and that oral steroid-dependent asthmatics have more peripheral airway disease than nonsteroid-dependent asthmatics. This suggests that patients on chronic oral steroid treatment have more extensive disease and require additional anti-inflammatory treatment to better target the peripheral airways.


The Journal of Allergy and Clinical Immunology | 2008

Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma

Annelies M. Slats; Kirsten Janssen; Annemarie van Schadewijk; Dirk T. van der Plas; Robert Schot; Joost G. van den Aardweg; Johan C. de Jongste; Pieter S. Hiemstra; Thais Mauad; Klaus F. Rabe; Peter J. Sterk

BACKGROUND Smooth muscle content is increased within the airway wall in patients with asthma and is likely to play a role in airway hyperresponsiveness. However, smooth muscle cells express several contractile and structural proteins, and each of these proteins may influence airway function distinctly. OBJECTIVE We examined the expression of contractile and structural proteins of smooth muscle cells, as well as extracellular matrix proteins, in bronchial biopsies of patients with asthma, and related these to lung function, airway hyperresponsiveness, and responses to deep inspiration. METHODS Thirteen patients with asthma (mild persistent, atopic, nonsmoking) participated in this cross-sectional study. FEV(1)% predicted, PC(20) methacholine, and resistance of the respiratory system by the forced oscillation technique during tidal breathing and deep breath were measured. Within 1 week, a bronchoscopy was performed to obtain 6 bronchial biopsies that were immunohistochemically stained for alpha-SM-actin, desmin, myosin light chain kinase (MLCK), myosin, calponin, vimentin, elastin, type III collagen, and fibronectin. The level of expression was determined by automated densitometry. RESULTS PC(20) methacholine was inversely related to the expression of alpha-smooth muscle actin (r = -0.62), desmin (r = -0.56), and elastin (r = -0.78). In addition, FEV(1)% predicted was positively related and deep inspiration-induced bronchodilation inversely related to desmin (r = -0.60), MLCK (r = -0.60), and calponin (r = -0.54) expression. CONCLUSION Airway hyperresponsiveness, FEV(1)% predicted, and airway responses to deep inspiration are associated with selective expression of airway smooth muscle proteins and components of the extracellular matrix.


Respiratory Research | 2009

Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients

Rembert Koczulla; Silvano Dragonieri; Robert Schot; Robert Bals; Stefanie A. Gauw; Claus Vogelmeier; Klaus F. Rabe; Peter J. Sterk; Pieter S. Hiemstra

BackgroundAnalysis of exhaled breath condensate (EBC) is a non-invasive method for studying the acidity (pH) of airway secretions in patients with inflammatory lung diseases.AimTo assess the reproducibility of EBC pH for two commercially available devices (portable RTube and non-portable ECoScreen) in healthy controls, patients with asthma or COPD, and subjects suffering from an acute cold with lower-airway symptoms. In addition, we assessed the repeatability in healthy controls.MethodsEBC was collected from 40 subjects (n = 10 in each of the above groups) using RTube and ECoScreen. EBC was collected from controls on two separate occasions within 5 days. pH in EBC was assessed after degasification with argon for 20 min.ResultsIn controls, pH-measurements in EBC collected by RTube or ECoScreen showed no significant difference between devices (p = 0.754) or between days (repeatability coefficient RTube: 0.47; ECoScreen: 0.42) of collection. A comparison between EBC pH collected by the two devices in asthma, COPD and cold patients also showed good reproducibility. No differences in pH values were observed between controls (mean pH 8.27; RTube) and patients with COPD (pH 7.97) or asthma (pH 8.20), but lower values were found using both devices in patients with a cold (pH 7.56; RTube, p < 0.01; ECoScreen, p < 0.05).ConclusionWe conclude that pH measurements in EBC collected by RTube and ECoScreen are repeatable and reproducible in healthy controls, and are reproducible and comparable in healthy controls, COPD and asthma patients, and subjects with a common cold.


BMC Infectious Diseases | 2011

A longitudinal study of allergy and intestinal helminth infections in semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study)

Firdaus Hamid; Aprilianto E. Wiria; Linda J. Wammes; Maria M. M. Kaisar; Bertrand Lell; Iwan Ariawan; Hae-Won Uh; Heri Wibowo; Yenny Djuardi; Sitti Wahyuni; Robert Schot; Jaco J. Verweij; Ronald van Ree; Linda May; Erliyani Sartono; Maria Yazdanbakhsh; Taniawati Supali

BackgroundThe prevalence of asthma and atopic disease has been reported to be low in low income countries, however helminth infections are likely to be high among these communities. The question of whether helminth infections play a role in allergic diseases can best be addressed by intervention studies. None of the studies so far have been based on a large scale placebo-controlled trial.Method/DesignThis study was designed to assess how intestinal helminth infections can influence the immune response and atopic and allergic disorders in children in Indonesia. The relations between allergic outcomes and infection and lifestyle factors will be addressed. This study was set up among school-age children in semi urban and rural areas, located in Ende District of Flores Island, Indonesia. A randomized placebo-controlled anthelmintic treatment trial to elucidate the impact of helminth infections on the prevalence of skin prick test (SPT) reactivity and symptoms of allergic diseases will be performed. The children living in these semi-urban and rural areas will be assessed for SPT to allergens before and after 1 and 2 years of treatment as the primary outcome of the study; the secondary outcome is symptoms (asthma and atopic dermatitis); while the tertiary outcome is immune responses (both antibody levels to allergens and cellular immune responses).DiscussionThe study will provide information on the influence of helminth infections and anthelmintic treatment on immune response, atopy and allergic disorders.Trial registrationCurrent Controlled Trials ISRCTN: ISRCTN83830814


Journal of Applied Physiology | 2008

Enhanced airway dilation by positive-pressure inflation of the lungs compared with active deep inspiration in patients with asthma

Annelies M. Slats; Kirsten Janssen; Ronald C. de Jeu; Dirk T. van der Plas; Robert Schot; Joost G. van den Aardweg; Peter J. Sterk

Deep inspiration temporarily reduces induced airways obstruction in healthy subjects. This bronchodilatory effect of deep inspiration is impaired in asthma. Passive machine-assisted lung inflation may augment bronchodilation compared with an active deep inspiration in patients with asthma by either opening closed airways or by reducing fluid flux across the airway wall during deep inspiration, and thereby increasing the tethering forces on the airway wall. We recruited 24 patients with asthma [18-46 yr old, forced expiratory volume in 1 s (FEV(1)) > 70% predicted; provocative concentration of methacholine inducing a 20% fall in FEV(1) (PC(20)) < 8 mg/ml], with either an impaired (n = 12) or an intact (n = 12) bronchodilatory response to deep inspiration. Two methacholine challenges were performed on separate days. At a 50% increase in respiratory resistance (forced oscillation technique at 8 Hz), the change in resistance by a positive-pressure inflation (computer-driven syringe) or an active deep inspiration was measured in randomized order. The reduction in resistance by positive-pressure inflation was significantly greater than by active deep inspiration in the impaired deep inspiration response group (mean change +/- SE: -0.6 +/- 0.1 vs. -0.03 +/- 0.2 cmH(2)O.l(-1).s, P = 0.002). No significant difference was found between positive-pressure inflation and active deep inspiration in the intact deep inspiration response group (-0.6 +/- 0.2 vs. -1.0 +/- 0.3 cmH(2)O.l(-1).s, P = 0.18). Positive-pressure inflation of the lungs can significantly enhance deep inspiration-induced bronchodilation in patients with asthma.


Respiration | 2008

A Syringe Simulation of Biological Controls for Quality Assessment of Prospective Lung Volume Measurements

Maarten K. Ninaber; Robert Schot; Laura Fregonese; Jan Stolk

Background: At present a syringe is being used for calibration of lung function devices, but biological controls are used to detect prospectively the variability and reproducibility of lung volumes measured by spirometers. Laboratory personnel is often used as biological control and therefore the cost for these measurements is substantial and may be reduced by replacement of a syringe procedure to increase the capacity of the laboratory to measure more patients. Objectives: To develop a mechanical syringe procedure for identification of instrument problems. Methods: A commercial 3-liter precision syringe is used to simulate breathing maneuvers (inspiratory vital capacity, functional residual capacity, residual volume and total lung capacity) on a spirometer. Three healthy males representing biological controls performed spirometry, maximum expiratory flow volume and helium dilution forced residual capacity at bimonthly intervals for 3 years. Confidence intervals and interval widths are calculated for each parameter. Levene’s test for equality of variances was used to test for significance between standard deviations. Results: The interval width of inspiratory vital capacity, functional residual capacity, total lung capacity and residual volume of repeated measurements obtained from the syringe was significantly narrower than those of biological controls. In addition, almost all standard deviations from lung volumes obtained from the syringe were smaller and significantly different from those of the biological control. Conclusion: Our syringe procedure may replace biological controls for detection of variability of lung volumes. This will result in cost reduction and improve quality assessment of lung function devices.


The Journal of Allergy and Clinical Immunology | 2007

An electronic nose in the discrimination of patients with asthma and controls

Silvano Dragonieri; Robert Schot; Bart Mertens; Saskia le Cessie; Stefanie A. Gauw; Antonio Spanevello; Onofrio Resta; Nico Willard; Teunis Johannes Vink; Klaus F. Rabe; Elisabeth H. Bel; Peter J. Sterk


American Journal of Respiratory and Critical Care Medicine | 2007

Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease

Annelies M. Slats; Kirsten Janssen; Annemarie van Schadewijk; Dirk T. van der Plas; Robert Schot; Joost G. van den Aardweg; Johan C. de Jongste; Pieter S. Hiemstra; Thais Mauad; Klaus F. Rabe; Peter J. Sterk


Radiology | 2003

Real-Time MR Imaging of Aortic Flow: Influence of Breathing on Left Ventricular Stroke Volume in Chronic Obstructive Pulmonary Disease

Rik J. van den Hout; Hildo J. Lamb; Joost G. van den Aardweg; Robert Schot; Paul Steendijk; Ernst E. van der Wall; Jeroen J. Bax; Albert de Roos

Collaboration


Dive into the Robert Schot's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joost G. van den Aardweg

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Annelies M. Slats

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Dirk T. van der Plas

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Kirsten Janssen

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Pieter S. Hiemstra

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Silvano Dragonieri

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Stefanie A. Gauw

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge